Europe Brain Cancer Diagnostic Market to 2032

Overview

The Europe Brain Cancer Diagnostic Market is expected to reach a 2,669.97 USD Billion by 2032 and is projected to grow at a CAGR of 26.93% from 2025 to 2032.

Revenue, 2024 (USD Billion)
698.94
Forecast, 2032 (USD Billion)
2,669.97
CAGR, 2024 - 2032
26.93%
Report Coverage
Europe

Europe Brain Cancer Diagnostic Market 2018-2032 USD Billion

Europe Brain Cancer Diagnostic Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 698.94 USD Billion
  • Projected Market Size (2032): 2,669.97 USD Billion
  • CAGR (2025-2032): 26.93%

Key Findings of Europe Brain Cancer Diagnostic Market

  • The Europe Brain Cancer Diagnostic Market was valued at 698.94 USD Billion in 2024.
  • The Europe Brain Cancer Diagnostic Market is likely to grow at a CAGR of 26.93% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Imaging Test in Test Segment accounted for the largest share of the market with a revenue of 244.04 USD Billion
  • The fastest growing segment 35-65 in Age Group Segment grew Fastest with a CAGR of 29.08% during the forecast period from 2024 to 2032.

Europe Brain Cancer Diagnostic Market Scope

Europe Brain Cancer Diagnostic Market Segmentation & Scope
End User
  • Others
  • Ambulatory Surgical Centers
  • Diagnostic Centers & Research Institutes
  • Specialty Clinics
  • Hospitals
Age Group
  • 21-34
  • Below 21
  • 65 and above
  • 35-65
Cancer
  • Others
  • Oligodendroglioma
  • Acoustic Neuroma
  • Astrocytomas
  • Meningiomas
  • Glioblastoma Multiforme
Test
  • Others
  • Biopsy
  • Lumbar Puncture
  • Electroencephalography (EEG)
  • Molecular Testing
  • Imaging Test

Europe Brain Cancer Diagnostic Market Data Coverage Insights

Study Period 2024-2032
Base Year 2021
Unit Revenue in USD Billion
Market Value in 2024 698.94 USD Billion
Market Value in 2032 2,669.97 USD Billion
CAGR (2025-2032) 26.93%
Historic Data 2016-2023
Market Segments Covered End User,Age Group,Cancer,Test

Regional Insights:

  • Leading Market (2024-2032): Europe, leading in terms of revenue 698.94 USD Billion in 2024
    • Key Country: Germany, leading in terms of revenue with value of 104.28 USD Billion in 2024.

Segments and Scope

  • Europe Brain Cancer Diagnostic Market to 2032, By End User
    • Hospitals is the largest segment in Europe Brain Cancer Diagnostic Market to 2032 with a revenue of 238.88 USD Billion in the year 2024.
    • Hospitals is the Fastest growing segment in Europe Brain Cancer Diagnostic Market to 2032 with a Growth rate of 28.83 % in forecast period 2025-2032.
  • Europe Brain Cancer Diagnostic Market to 2032, By Age Group
    • 35-65 is the largest segment in Europe Brain Cancer Diagnostic Market to 2032 with a revenue of 226.64 USD Billion in the year 2024.
    • 35-65 is the Fastest growing segment in Europe Brain Cancer Diagnostic Market to 2032 with a Growth rate of 29.08 % in forecast period 2025-2032.
  • Europe Brain Cancer Diagnostic Market to 2032, By Cancer
    • Glioblastoma Multiforme is the largest segment in Europe Brain Cancer Diagnostic Market to 2032 with a revenue of 216.53 USD Billion in the year 2024.
    • Glioblastoma Multiforme is the Fastest growing segment in Europe Brain Cancer Diagnostic Market to 2032 with a Growth rate of 28.83 % in forecast period 2025-2032.
  • Europe Brain Cancer Diagnostic Market to 2032, By Test
    • Imaging Test is the largest segment in Europe Brain Cancer Diagnostic Market to 2032 with a revenue of 244.04 USD Billion in the year 2024.
    • Imaging Test is the Fastest growing segment in Europe Brain Cancer Diagnostic Market to 2032 with a Growth rate of 28.79 % in forecast period 2025-2032.

Europe Brain Cancer Diagnostic Market Company Share Analysis

 
Company Name Company Share Analysis
NIHON KOHDEN CORPORATION
Neusoft Corporation
Koninklijke Philips N.V.
CANON MEDICAL SYSTEMS CORPORATION
Siemens Healthcare GmbH
Europe Brain Cancer Diagnostic Market Company Share Analysis

Europe Brain Cancer Diagnostic Market Geographical Sales Distribution, 2018-2032 USD Billion

Europe Brain Cancer Diagnostic Market Geographical Sales Distribution, 2018-2032 USD Billion

Europe Brain Cancer Diagnostic Market Company Profiling

Europe Brain Cancer Diagnostic Market Company Profiling
Frequently Asked Questions
The Europe Brain Cancer Diagnostic Market is segmented based on Segmentation End User,Age Group,Cancer,Test.
Europe Brain Cancer Diagnostic Market was valued at USD 698.94(Revenue in USD Billion) in 2021.
Europe Brain Cancer Diagnostic Market is projected to grow at a CAGR of 26.93% during the forecast period of 2024 to 2032.
The Imaging Test segment is expected to dominate the Europe Brain Cancer Diagnostic Market, holding a largest market share of 244.04 USD Billion in 2024

Europe Brain Cancer Diagnostic Market Scope

Europe Brain Cancer Diagnostic Market Segmentation & Scope
End User
  • Others
  • Ambulatory Surgical Centers
  • Diagnostic Centers & Research Institutes
  • Specialty Clinics
  • Hospitals
Age Group
  • 21-34
  • Below 21
  • 65 and above
  • 35-65
Cancer
  • Others
  • Oligodendroglioma
  • Acoustic Neuroma
  • Astrocytomas
  • Meningiomas
  • Glioblastoma Multiforme
Test
  • Others
  • Biopsy
  • Lumbar Puncture
  • Electroencephalography (EEG)
  • Molecular Testing
  • Imaging Test
Frequently Asked Questions
The Europe Brain Cancer Diagnostic Market is segmented based on Segmentation End User,Age Group,Cancer,Test.
Europe Brain Cancer Diagnostic Market was valued at USD 698.94(Revenue in USD Billion) in 2021.
Europe Brain Cancer Diagnostic Market is projected to grow at a CAGR of 26.93% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Brain Cancer Diagnostic Market for final year is USD 2,669.97 (USD Billion).

Europe Brain Cancer Diagnostic Market Company Profiling

Europe Brain Cancer Diagnostic Market Company Profiling
Frequently Asked Questions
The Europe Brain Cancer Diagnostic Market is segmented based on Segmentation End User,Age Group,Cancer,Test.
Europe Brain Cancer Diagnostic Market was valued at USD 698.94(Revenue in USD Billion) in 2021.
Europe Brain Cancer Diagnostic Market is projected to grow at a CAGR of 26.93% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Brain Cancer Diagnostic Market for final year is USD 2,669.97 (USD Billion).

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 8500.00

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.